Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash from Operations: 2010-2024

Historic Cash from Operations for CorMedix (CRMD) over the last 14 years, with Dec 2024 value amounting to -$50.6 million.

  • CorMedix's Cash from Operations rose 326.06% to $30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.0 million, marking a year-over-year increase of 235.34%. This contributed to the annual value of -$50.6 million for FY2024, which is 31.78% down from last year.
  • According to the latest figures from FY2024, CorMedix's Cash from Operations is -$50.6 million, which was down 31.78% from -$38.4 million recorded in FY2023.
  • In the past 5 years, CorMedix's Cash from Operations ranged from a high of -$21.2 million in FY2021 and a low of -$50.6 million during FY2024.
  • Its 3-year average for Cash from Operations is -$37.8 million, with a median of -$38.4 million in 2023.
  • Per our database at Business Quant, CorMedix's Cash from Operations rose by 3.70% in 2021 and then plummeted by 57.70% in 2023.
  • CorMedix's Cash from Operations (Yearly) stood at -$22.0 million in 2020, then grew by 3.70% to -$21.2 million in 2021, then fell by 15.13% to -$24.4 million in 2022, then plummeted by 57.70% to -$38.4 million in 2023, then plummeted by 31.78% to -$50.6 million in 2024.